(Q34825044)

4 August 2017

1 reference

title

Angiotensin II and progressive renal insufficiency (English)

1 reference

4 August 2017

Jens Gaedeke

1

1 reference

4 August 2017

Nancy A Noble

series ordinal

2

1 reference

4 August 2017

Wayne A Border

series ordinal

3

1 reference

4 August 2017

publication date

1 October 2002

1 reference

Current Hypertension Reports

4 August 2017

published in

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

403-407

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-002-0071-9

4 August 2017

exact match

0 references

cites work

Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-002-0071-9

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-002-0071-9

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-002-0071-9

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

12 December 2020

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction

1 reference

12 December 2020

Transforming growth factor beta in hypertensives with cardiorenal damage

1 reference

12 December 2020

t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

12 December 2020

Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney

1 reference

12 December 2020

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

1 reference

12 December 2020

Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts

1 reference

12 December 2020

Angiotensin II, TGF-beta and renal fibrosis

1 reference

12 December 2020

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

12 December 2020

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

12 December 2020

Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart

1 reference

12 December 2020

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

12 December 2020

Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study

1 reference

12 December 2020

Transforming growth factor beta in tissue fibrosis

1 reference

12 December 2020

Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice

1 reference

12 December 2020

Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage

1 reference

12 December 2020

Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction

1 reference

12 December 2020

Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta

1 reference

12 December 2020

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

12 December 2020

Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1

1 reference

12 December 2020

Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis

1 reference

12 December 2020

Role of aldosterone in the remnant kidney model in the rat.

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

12 December 2020

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

12 December 2020

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

1 reference

12 December 2020

Resistance to remnant nephropathy in the Wistar-Furth rat.

1 reference

12 December 2020

Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin

1 reference

12 December 2020

Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage

1 reference

12 December 2020

Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES

1 reference

12 December 2020

Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy

1 reference

12 December 2020

10.1007/S11906-002-0071-9

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1016007483

0 references

1 reference